These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9879511)

  • 1. The mechanism of binding of low-molecular-weight active site inhibitors to human alpha-thrombin.
    Nilsson T; Sjöling-Ericksson A; Deinum J
    J Enzyme Inhib; 1998 Feb; 13(1):11-29. PubMed ID: 9879511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.
    Brandstetter H; Turk D; Hoeffken HW; Grosse D; Stürzebecher J; Martin PD; Edwards BF; Bode W
    J Mol Biol; 1992 Aug; 226(4):1085-99. PubMed ID: 1518046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis.
    Elg M; Gustafsson D; Deinum J
    Thromb Haemost; 1997 Oct; 78(4):1286-92. PubMed ID: 9364999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of new NAPAP-analogs.
    Steinmetzer T; Schweinitz A; Künzel S; Wikström P; Hauptmann J; Stürzebecher J
    J Enzyme Inhib; 2001; 16(3):241-9. PubMed ID: 11697044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor binding to thrombin: x-ray crystallographic studies.
    Banner DW; Hadváry P
    Adv Exp Med Biol; 1993; 340():27-33. PubMed ID: 8154341
    [No Abstract]   [Full Text] [Related]  

  • 6. Design, synthesis and biological activity of novel rigid amidino-phenylalanine derivatives as inhibitors of thrombin.
    Mack H; Pfeiffer T; Hornberger W; Böhm HJ; Höffken HW
    J Enzyme Inhib; 1995; 9(1):73-86. PubMed ID: 8568568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geometry of binding of the benzamidine- and arginine-based inhibitors N alpha-(2-naphthyl-sulphonyl-glycyl)-DL-p-amidinophenylalanyl-pipe ridine (NAPAP) and (2R,4R)-4-methyl-1-[N alpha-(3-methyl-1,2,3,4-tetrahydro-8- quinolinesulphonyl)-L-arginyl]-2-piperidine carboxylic acid (MQPA) to human alpha-thrombin. X-ray crystallographic determination of the NAPAP-trypsin complex and modeling of NAPAP-thrombin and MQPA-thrombin.
    Bode W; Turk D; Stürzebecher J
    Eur J Biochem; 1990 Oct; 193(1):175-82. PubMed ID: 2226434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of endothelial cell-mediated generation of activated protein C by direct and antithrombin-dependent thrombin inhibitors.
    Linder R; Frebelius S; Jansson K; Swedenborg J
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):139-46. PubMed ID: 12632023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors.
    Banner DW; Hadváry P
    J Biol Chem; 1991 Oct; 266(30):20085-93. PubMed ID: 1939071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A thermodynamic characterization of the binding of thrombin inhibitors to human thrombin, combining biosensor technology, stopped-flow spectrophotometry, and microcalorimetry.
    Deinum J; Gustavsson L; Gyzander E; Kullman-Magnusson M; Edström A; Karlsson R
    Anal Biochem; 2002 Jan; 300(2):152-62. PubMed ID: 11779106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design and synthesis of novel thrombin inhibitors based on phosphinic peptide mimetics.
    Li M; Lin Z; Johnson ME
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1957-62. PubMed ID: 10450962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-dependent binding constants for the inhibition of thrombin by transition state analogs.
    Philipp M; Niua LH; DeSoyza T; Claeson G; Metternich R
    Adv Exp Med Biol; 1993; 340():67-77. PubMed ID: 8154344
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of melagatran, a new low-molecular-weight thrombin inhibitor, on thrombin and fibrinolytic enzymes.
    Gustafsson D; Antonsson T; Bylund R; Eriksson U; Gyzander E; Nilsson I; Elg M; Mattsson C; Deinum J; Pehrsson S; Karlsson O; Nilsson A; Sörensen H
    Thromb Haemost; 1998 Jan; 79(1):110-8. PubMed ID: 9459334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation.
    Warkentin TE; Greinacher A; Craven S; Dewar L; Sheppard JA; Ofosu FA
    Thromb Haemost; 2005 Nov; 94(5):958-64. PubMed ID: 16363236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin-induced platelet activation and its inhibition by anticoagulants with different modes of action.
    Nylander S; Mattsson C
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):159-67. PubMed ID: 12632026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of new NAPAP-analogs.
    Steinmetzer T; Schweinitz A; Künzel S; Wikström P; Hauptmann J; Stürzebecher J
    J Enzyme Inhib Med Chem; 2002 Apr; 17(2):241-9. PubMed ID: 12420761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterisation of novel thrombin inhibitors based on 4-amidinophenylalanine.
    Reers M; Koschinsky R; Dickneite G; Hoffmann D; Czech J; Stüber W
    J Enzyme Inhib; 1995; 9(1):61-72. PubMed ID: 8568567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of extrinsic and intrinsic thrombin generation by a novel synthetic thrombin inhibitor (Ro 46-6240), recombinant hirudin and heparin in human plasma.
    Gast A; Tschopp TB
    Blood Coagul Fibrinolysis; 1995 Sep; 6(6):553-60. PubMed ID: 7578898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A screening procedure to evaluate the anticoagulant activity and the kinetic behaviour of direct thrombin inhibitors.
    Rupin A; Mennecier P; de Nanteuil G; Laubie M; Verbeuren TJ
    Thromb Res; 1995 May; 78(3):217-25. PubMed ID: 7631302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of inhibitors derived from 3-amidinophenylalanine.
    Stürzebecher J; Prasa D; Wikström P; Vieweg H
    J Enzyme Inhib; 1995; 9(1):87-99. PubMed ID: 8568569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.